| Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer HB Grossman, RB Natale, CM Tangen, VO Speights, NJ Vogelzang, ... New England Journal of Medicine 349 (9), 859-866, 2003 | 2670 | 2003 |
| Vitamin D signalling pathways in cancer: potential for anticancer therapeutics KK Deeb, DL Trump, CS Johnson Nature reviews cancer 7 (9), 684-700, 2007 | 1797 | 2007 |
| Hypersensitivity reactions from taxol. RB Weiss, RC Donehower, PH Wiernik, T Ohnuma, RJ Gralla, DL Trump, ... Journal of clinical oncology 8 (7), 1263-1268, 1990 | 1500 | 1990 |
| Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer EM Messing, J Manola, M Sarosdy, G Wilding, ED Crawford, D Trump New England Journal of Medicine 341 (24), 1781-1788, 1999 | 1477 | 1999 |
| Hydrocortisone with or without mitoxantrone in men with hormone-refractory prostate cancer: results of the cancer and leukemia group B 9182 study PW Kantoff, S Halabi, M Conaway, J Picus, J Kirshner, V Hars, D Trump, ... Journal of Clinical Oncology 17 (8), 2506-2506, 1999 | 1148 | 1999 |
| Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group GJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ... Journal of Clinical Oncology 17 (11), 3461-3467, 1999 | 1126 | 1999 |
| Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy EM Messing, J Manola, J Yao, M Kiernan, D Crawford, G Wilding, ... The lancet oncology 7 (6), 472-479, 2006 | 1053 | 2006 |
| Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: A phase III trial (CALGB 9583). Small EJ, Halabi S, Dawson … DL Trump Urologic Oncology: Seminars and Original Investigations 22 (5), 433, 2004 | 640 | 2004 |
| An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. K Antman, J Crowley, SP Balcerzak, SE Rivkin, GR Weiss, A Elias, ... Journal of clinical oncology 11 (7), 1276-1285, 1993 | 591 | 1993 |
| Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial … SB Saxman, KJ Propert, LH Einhorn, ED Crawford, I Tannock, ... Journal of Clinical oncology 15 (7), 2564-2569, 1997 | 578 | 1997 |
| Prognostic factors for survival in patients with recurrent or metastatic renal cell carcinoma PJ Elson, RS Witte, DL Trump Cancer research 48 (24_Part_1), 7310-7313, 1988 | 446 | 1988 |
| Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer SL Greenspan, P Coates, SM Sereika, JB Nelson, DL Trump, NM Resnick The Journal of Clinical Endocrinology & Metabolism 90 (12), 6410-6417, 2005 | 435 | 2005 |
| Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species SV Singh, SK Srivastava, S Choi, KL Lew, J Antosiewicz, D Xiao, Y Zeng, ... Journal of Biological Chemistry 280 (20), 19911-19924, 2005 | 409 | 2005 |
| Bladder cancer PE Clark, N Agarwal, MC Biagioli, MA Eisenberger, RE Greenberg, ... Journal of the National Comprehensive Cancer Network 11 (4), 446-475, 2013 | 396 | 2013 |
| Trastuzumab, Paclitaxel, Carboplatin, and Gemcitabine in Advanced Human Epidermal Growth Factor Receptor-2/neu–Positive Urothelial Carcinoma: Results of a … MHA Hussain, GR MacVicar, DP Petrylak, RL Dunn, U Vaishampayan, ... Journal of Clinical Oncology 25 (16), 2218-2224, 2007 | 395 | 2007 |
| Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. SA Grossman, DM Finkelstein, JC Ruckdeschel, DL Trump, T Moynihan, ... Journal of clinical oncology 11 (3), 561-569, 1993 | 383 | 1993 |
| Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial EM Messing, J Manola, G Wilding, K Propert, J Fleischmann, ED Crawford, ... Journal of clinical oncology 21 (7), 1214-1222, 2003 | 374 | 2003 |
| Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial SL Greenspan, JB Nelson, DL Trump, NM Resnick Annals of Internal Medicine 146 (6), 416-424, 2007 | 361 | 2007 |
| The role of vitamin D in cancer prevention and treatment AV Krishnan, DL Trump, CS Johnson, D Feldman Rheumatic Disease Clinics 38 (1), 161-178, 2012 | 350 | 2012 |
| Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits proliferation of human prostate cancer cells by causing G 2 /M arrest and inducing … D Xiao, SK Srivastava, KL Lew, Y Zeng, P Hershberger, CS Johnson, ... Carcinogenesis 24 (5), 891-897, 2003 | 318 | 2003 |
